Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. [electronic resource]
Producer: 20110113Description: 678-80 p. digitalISSN:- 1873-2402
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.